Northwest Biotherapeutics, Inc. ( NWBO) - Key Metrics
NWBO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2024Q3 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2024Q2 | $0 | -$0.01 | -$0.01 | -$0.01 |
| 2024Q1 | $0 | -$0.02 | -$0.01 | -$0.01 |
| 2023Q4 | $0 | -$0.02 | -$0.01 | -$0.02 |
| 2023Q3 | $0 | -$0.02 | -$0.01 | -$0.01 |
NWBO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2024Q3 | -2.26% | -5.16 |
| 2024Q2 | -2.47% | -6.97 |
| 2024Q1 | ? | -8.43 |
| 2023Q4 | ? | -10.73 |
| 2023Q3 | ? | -13.51 |
NWBO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2024Q3 | -1.86% | 0.11% |
| 2024Q2 | -3.36% | 0.09% |
| 2024Q1 | -2.05% | ? |
| 2023Q4 | -2.14% | ? |
| 2023Q3 | -1.39% | ? |
NWBO
Price: $0.19
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.06 USD
P/E Ratio: -3.73
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.3 million
Ebitda: -69.1 millionMarket Capitalization: 328.7 million